Drawing for CELLPROTHERA

USPTO serial 79076423

CELLPROTHERA

Reviewed by CopyMark Law Group

Reg. 3980163Status 404
Filing date
Status date
Registration date
Jun 21, 2011
Examiner
ROACH, APRIL K
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CELLPROTHERA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jonathan Myers

Jonathan Myers and Andrew Wilford K.F. ROSS P.C.5683 RIVERDALE AVENUE BOX 900CUSTOMER NUMBER 535BRONX, NY 10471-0900

Goods and services

ClassDescriptionStatusFirst use
005Biological preparations for cell cultures; cell culture media, namely, culture media for endothelial and myocardiac cells; culture media for cell growth for medical biotechnology, namely,culture media for growing and regenerating endothelial and myocardiac cells; biological reagents for molecular biology; chemical reagents for medical use for biological processes; carriers of culture media for medical use, namely, Iscove's modified Dulbecco's medium, used for rapidly proliferating high density cell cultures; cellular function activating agents, namely,cell growth factors, hematopoietic factors, serums, namely, human and animal serums for cell culture; antibodies, namely, monoclonal antibodies for detection and treatment of pathologies; all these products being for medical useSECTION 71 - CANCELLED—
010Medical apparatus and instruments, namely, intravascular cell reinjection catheters; apparatus for human cell culture, namely, medical device for providing human cell culture diagnosis and treatment; cell analyzers for medical treatment and diagnostic use; medical device for production of human cell grafts, namely, medical device allowing in vitro stem cell expansion for therapeutic use; instruments for cell culture, namely, medical instruments used for cell culture diagnosis and treatment; medical device for human cell selection, namely, medical device for human cell immune selection used for diagnosis and treatmentSECTION 71 - CANCELLED—
042Research and development of new products in the field of biotechnology; services for scientific analysis for medical purposes, namely, medical research laboratory services; development of new products for medical research for third partiesSECTION 71 - CANCELLED—
044Medical care and treatment; medical services for cell sampling and isolation, namely, leukapheresis medical treatment services; services for medical analysis relating to treating individuals, namely, behavior analysis for medical purposes; therapeutic treatment, namely, cell therapy for regenerative medicineSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 30, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 29, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 4, 2021GPNXNOTIFICATION PROCESSED BY IB—
Aug 29, 2020RFNTREFUSAL PROCESSED BY IB—
Feb 21, 2020DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Feb 21, 2020DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 22, 2019ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Aug 1, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 14, 2018INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 27, 2018INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 27, 2018INPCINVALIDATION PROCESSED—
Sep 26, 2018INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 26, 2018C71TCANCELLED SECTION 71—
May 14, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 17, 2011FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 17, 2011FIMPFINAL DISPOSITION PROCESSED—
Sep 21, 2011FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 21, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 11, 2011OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 25, 2011OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 25, 2011OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 5, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 17, 2011OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 17, 2011OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 16, 2011NPUBNOTICE OF PUBLICATION—
Mar 2, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 2, 2011ALIEASSIGNED TO LIE—
Feb 2, 2011ALIEASSIGNED TO LIE—
Jan 31, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 24, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 24, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 24, 2011ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 11, 2010CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 10, 2010CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 10, 2010DMCCDATA MODIFICATION COMPLETED—
Jul 20, 2010ACECAMENDMENT FROM APPLICANT ENTERED—
Jul 20, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 17, 2010ALIEASSIGNED TO LIE—
Jul 6, 2010MAILPAPER RECEIVED—
Jan 29, 2010RFNTREFUSAL PROCESSED BY IB—
Jan 6, 2010RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 6, 2010RFRRREFUSAL PROCESSED BY MPU—
Jan 6, 2010RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 5, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 2, 2010MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 29, 2009DOCKASSIGNED TO EXAMINER—
Dec 29, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 24, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance